Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Clinical Data Updates & Treatment Management Strategies in First-line ALK-positive Metastatic Non-Small Cell Lung Cancer(NSCLC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    BOOST - Multiple Myeloma An Oncology Boosting Program
    Release Date:
    Review Process: Expert Review Panel
    Translation:(link)
    Quality Improvement Oncology Netherlands
    PARP-Inhibitor Combination Treatments: Safety and Efficacy in a rapidly changing mCRPC landscape
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Education in the Era of Emerging Hemophilia Therapy
    Release Date:
    Partner: National Bleeding Disorders Foundation
    Review Process: Expert Review Panel
    Education Rare Disease Guam, Puerto Rico, USA
    Education for Patients and Caregivers Living with Bladder Cancer from NMIBC to la/mUC
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    USP <797> Pharmaceutical Compounding-Sterile Preparations: Ensuring Compliance Now and For the Future
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    COVID-19 Burden and Benefit of Vaccination - Global excluding US, Canada and Taiwan
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines All
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Promote Understanding of Respiratory Infections (Streptococcus pneumoniae, Influenza virus, RSV, GBS, SARS-Cov-2)
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Japan
    Increasing the Awareness of the Importance of Vaccination during Pregnancy
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Japan
    Understanding Alopecia Areata for Dermatologists, Pediatric Dermatologists, and Advanced Practice Providers
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Capacity Building for Antimicrobial Stewardship
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital Japan
    Implementation of Systemic Treatment Approaches in Atopic Dermatitis
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology China
    Oncology Capacity Building in Sub-Saharan Africa (including CABO VERDE and ESWATINI)
    Release Date:
    Partner: Mayo Clinic Global Bridges Oncology
    Review Process: Expert Review Panel
    Translation: French (link)
    Translation:(link)
    Quality Improvement Oncology Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Central African Republic, Chad, Comoros, Congo, Congo, The Democratic Republic, Cote D'ivoire, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-bissau, Kenya, Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Mauritius, Mozambique, Namibia, Niger, Nigeria, Rwanda, Sao Tome and Principe, Senegal, Seychelles, Sierra Leone, Somalia, South Africa, Sudan, Tanzania, United Republic of, Togo, Uganda, Zambia, Zimbabwe
    Improving Clinical Management for Patients with Breast Cancer in China
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology China
    NSCLC Cancer Precision Diagnosis and Treatment
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology China
    Advancing Management and Care in Atrial Fibrillation and Venous Thromboembolism
    Release Date:
    Partner: BMS
    Review Process: Pfizer Internal
    Education Internal Medicine All
    Addressing Knowledge Gaps in Aplastic Anemia
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Knowledge Gaps in Treatment of Acute COVID-19 and Management of Post-COVID Conditions in Outpatient Settings
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Digital Education to Address Patients with COVID-19 and High Risk of Complications
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All